Ƶ

Morning Break: HIV Quad Pill OK'd; Hep A Outbreak Simmers; Attack of the Angry Bees

— Health news and commentary from around the Web gathered by the Ƶ staff

Ƶ MedicalToday

Note that some links may require subscriptions.

Janssen's , the company said. To be sold as Symtuza, the product also contains cobicistat, emtricitabine, and tenofovir alafenamide.

A federal appeals court by hospitals slated for budget cuts under the 340B drug discount program; the court ruled that the hospitals didn't have standing to sue because they have not yet been affected by the cuts. (Modern Healthcare)

A to find a deadly disease: 3-D color X-rays. (The New York Times)

FDA tightrope walking: the agency announces a new initiative to "to include indications that have not, historically, been available for use without a prescription" -- but also without relaxing "the evidentiary standards needed" for OTC products.

Do urgent care clinics prescribe too many antibiotics? . (The Washington Post)

Eleven states are of hepatitis A. (WCYB.com)

Bill Gates and some other investors are to find a way to diagnose Alzheimer's earlier. (Business Insider)

The Toronto Board of Health is as part of a strategy to fight the overdose crisis in that country. (Globe and Mail)

CDC director Robert Redfield, MD, to the opioid crisis. (CBS News)

But the U.S. is also facing a shortage of some legitimate opioid painkillers. Now, one supplier says it's . (Reuters)

Speaking of earlier diagnosis, an experimental blood test for melanoma. (CNN)

You think you had a bad day? Try . (The Washington Post)

Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the Ƶ community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.